Peripheral Arterial Disease (PAD) Clinical Trials

Medical Center of South Arkansas
El Dorado Arkansas 71730

Pivotal Study of the Safety and Effectiveness of Autologous Bone Marrow Aspirate Concentrate (BMAC) for the treatment of Critical Limb Ischemia due to Peripheral Arterial Occlusive Disease

USC Keck School of Medicine
Los Angeles California 90033

Pivotal Study of the Safety and Effectiveness of Autologous Bone Marrow Aspirate Concentrate (BMAC) for the treatment of Critical Limb Ischemia due to Peripheral Arterial Occlusive Disease

Cardiology Research Associates
Daytona Beach Florida 32117

A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease

Florida Hospital – Vascular Institute of Central Florida
Orlando Florida 32804

Pivotal Study of the Safety and Effectiveness of Autologous Bone Marrow Aspirate Concentrate (BMAC) for the treatment of Critical Limb Ischemia due to Peripheral Arterial Occlusive Disease

USF / Tampa General
Tampa Florida 33606

Pivotal Study of the Safety and Effectiveness of Autologous Bone Marrow Aspirate Concentrate (BMAC) for the treatment of Critical Limb Ischemia due to Peripheral Arterial Occlusive Disease

Metabolic Research Institute, Inc.
West Palm Beach Florida 33401

Do you have Peripheral Artery Disease (PAD)?

Cadence Health, Central DuPage Hospital
Winfield Illinois 60190

Pivotal Study of the Safety and Effectiveness of Autologous Bone Marrow Aspirate Concentrate (BMAC) for the treatment of Critical Limb Ischemia due to Peripheral Arterial Occlusive Disease

Ochsner Clinic
New Orleans Louisiana 70121

Pivotal Study of the Safety and Effectiveness of Autologous Bone Marrow Aspirate Concentrate (BMAC) for the treatment of Critical Limb Ischemia due to Peripheral Arterial Occlusive Disease

Maine Medical Ctr
Portland Maine 04102

Pivotal Study of the Safety and Effectiveness of Autologous Bone Marrow Aspirate Concentrate (BMAC) for the treatment of Critical Limb Ischemia due to Peripheral Arterial Occlusive Disease

Spectrum Clinical Research, Inc.
Baltimore Maryland 21236

A Study of AMR101 to Evaluate Its Ability to Reduce Cardiovascular Events in High Risk Patients With Hypertriglyceridemia and on Statin. The Primary Objective is to Evaluate the Effect of 4 g/Day AMR101 for Preventing the Occurrence of a First Major Cardiovascular Event. (REDUCE-IT)

Spectrum Clinical Research, Inc.
Baltimore Maryland 21236

Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk (FOURIER)

Johns Hopkins Hospital
Baltimore Maryland 21287

Pivotal Study of the Safety and Effectiveness of Autologous Bone Marrow Aspirate Concentrate (BMAC) for the treatment of Critical Limb Ischemia due to Peripheral Arterial Occlusive Disease

Beth Israel Deaconess
Boston Massachusetts 02215

Pivotal Study of the Safety and Effectiveness of Autologous Bone Marrow Aspirate Concentrate (BMAC) for the treatment of Critical Limb Ischemia due to Peripheral Arterial Occlusive Disease

Tufts Medical Center
Boston Massachusetts 02111

Pivotal Study of the Safety and Effectiveness of Autologous Bone Marrow Aspirate Concentrate (BMAC) for the treatment of Critical Limb Ischemia due to Peripheral Arterial Occlusive Disease

Kansas City Vascular
Kansas City Missouri 64116

Pivotal Study of the Safety and Effectiveness of Autologous Bone Marrow Aspirate Concentrate (BMAC) for the treatment of Critical Limb Ischemia due to Peripheral Arterial Occlusive Disease

Mercy Hospital
St. Louis Missouri
New

Pivotal Study of the Safety and Effectiveness of Autologous Bone Marrow Aspirate Concentrate (BMAC) for the treatment of Critical Limb Ischemia due to Peripheral Arterial Occlusive Disease

Dartmouth Hitchcock Medical Ctr
Lebanon New Hampshire 03756

Pivotal Study of the Safety and Effectiveness of Autologous Bone Marrow Aspirate Concentrate (BMAC) for the treatment of Critical Limb Ischemia due to Peripheral Arterial Occlusive Disease

Cooper University Hospital
Camden New Jersey 08103

Pivotal Study of the Safety and Effectiveness of Autologous Bone Marrow Aspirate Concentrate (BMAC) for the treatment of Critical Limb Ischemia due to Peripheral Arterial Occlusive Disease

Biomedical Research Alliance of New York
Manhasset New York 11030

Peripheral Arterial Disease

St. Luke’s Roosevelt
New York New York 10025

Pivotal Study of the Safety and Effectiveness of Autologous Bone Marrow Aspirate Concentrate (BMAC) for the treatment of Critical Limb Ischemia due to Peripheral Arterial Occlusive Disease

Rex Healthcare
Raleigh North Carolina 27607

A Randomized Trial of the Medtronic-Invatec IN.PACT Admiral Drug Eluting Balloon versus Standard Percutaneous Transluminal Angioplasty (PTA) for Treatment of Atherosclerotic Lesions in the Superficial Femoral and/or Proximal Popliteal (SFA/PPA) Arteries

Rex Healthcare
Raleigh North Carolina 27607

Absolute Pro® Peripheral Self-Expanding Stent System and the Absolute Pro® LL Peripheral Self-Expanding Stent Systems in the Treatment of Subjects With Atherosclerotic De Novo or Restenotic Lesions in the Native Superficial Femoral Artery and/or Native Proximal Popliteal Artery.

Rex Healthcare
Raleigh North Carolina 27607

Evaluation of Safety and Efficacy of the FlexStent® Femoropopliteal Self-Expanding Stent System Study

PMG Research of Wilmington
Wilmington North Carolina 28401

Do you experience physical limitations or discomfort with your Peripheral Artery Disease?

Wake Forest Baptist Health
Winston-Salem North Carolina

Pivotal Study of the Safety and Effectiveness of Autologous Bone Marrow Aspirate Concentrate (BMAC) for the treatment of Critical Limb Ischemia due to Peripheral Arterial Occlusive Disease

University of Cincinnati
Cincinnati Ohio 45267

Pivotal Study of the Safety and Effectiveness of Autologous Bone Marrow Aspirate Concentrate (BMAC) for the treatment of Critical Limb Ischemia due to Peripheral Arterial Occlusive Disease

Regional Infectious Disease and Infusion Ctr
Lima Ohio 45801

Pivotal Study of the Safety and Effectiveness of Autologous Bone Marrow Aspirate Concentrate (BMAC) for the treatment of Critical Limb Ischemia due to Peripheral Arterial Occlusive Disease

University of Oklahoma
Tulsa Oklahoma 74135

Pivotal Study of the Safety and Effectiveness of Autologous Bone Marrow Aspirate Concentrate (BMAC) for the treatment of Critical Limb Ischemia due to Peripheral Arterial Occlusive Disease

Oregon Health Sciences University
Portland Oregon 97239

Pivotal Study of the Safety and Effectiveness of Autologous Bone Marrow Aspirate Concentrate (BMAC) for the treatment of Critical Limb Ischemia due to Peripheral Arterial Occlusive Disease

Rhode Island Hospital
Providence Rhode Island 02903

Pivotal Study of the Safety and Effectiveness of Autologous Bone Marrow Aspirate Concentrate (BMAC) for the treatment of Critical Limb Ischemia due to Peripheral Arterial Occlusive Disease

Roper St Francis Medical Center
Charleston South Carolina 29401

Pivotal Study of the Safety and Effectiveness of Autologous Bone Marrow Aspirate Concentrate (BMAC) for the treatment of Critical Limb Ischemia due to Peripheral Arterial Occlusive Disease

PMG Research of Bristol
Bristol Tennessee 37620

Do you experience physical limitations or discomfort with your Peripheral Artery Disease?

Baylor Medical Ctr
Dallas Texas 75226

Pivotal Study of the Safety and Effectiveness of Autologous Bone Marrow Aspirate Concentrate (BMAC) for the treatment of Critical Limb Ischemia due to Peripheral Arterial Occlusive Disease

Peace Health Southwest Medical Center
Vancouver Washington 98682

Pivotal Study of the Safety and Effectiveness of Autologous Bone Marrow Aspirate Concentrate (BMAC) for the treatment of Critical Limb Ischemia due to Peripheral Arterial Occlusive Disease